Mr. McCaslin’s presentation discussed the role of intellectual property in personalized medicine. In particular, the program provided an overview of the patenting process and present strategies for securing global patent protection. We also discussed the impact of recent court cases on theranostic patent and propose tactics for navigating the minefield.
For more information on Mr. McCaslin’s presentation and the conference program, please visit http://www.personalizedmedicinepartnerships.com/.
Related Insights
December 19, 2025
Health Care Law Today
Gender Affirming Care for Minors: CMS and HHS Propose Limits on “Sex Rejection Procedures” and Expanded Enforcement Pathways
On December 18, 2025, the U.S. Department of Health and Human Services (HHS) held a press conference focused on what is defined as “sex…
December 19, 2025
Foley Viewpoints
Prohibition to Prescription: What Trump’s Marijuana Executive Order Really Means
On December 18, 2025, President Donald Trump issued an Executive Order, Increasing Medical Marijuana and Cannabidiol Research, that…
December 18, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…